• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

捷克医生对仿制药和替代药物认知的决定因素的代表性抽样调查

Representative sample survey on factors determining the Czech physicians' awareness of generic drugs and substitution.

机构信息

Faculty of Pharmacy in Hradec Kralove, Department of Social and Clinical Pharmacy, Charles University, Akademika Heyrovskeho 1203, 500 05, Hradec Kralove, Czech Republic.

Faculty of Pharmacy in Hradec Kralove, Czech Pharmaceutical Museum, Charles University, Akademika Heyrovskeho 1203, 500 05, Hradec Kralove, Czech Republic.

出版信息

BMC Health Serv Res. 2019 Oct 30;19(1):777. doi: 10.1186/s12913-019-4631-y.

DOI:10.1186/s12913-019-4631-y
PMID:31666059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6822393/
Abstract

BACKGROUND

Generic drugs and generic substitution belong to the tools by which healthcare costs may be reduced. However, low awareness and reluctance among healthcare professionals towards generic drugs may negatively affect the rational use of generic substitution.

METHODS

The study aimed to analyze opinions and attitudes towards generic drugs and generic substitution among Czech physicians including their understanding of generic substitution legislative rules and the physicians´ previous experience in this field. Using random allocation, 1551 physicians practicing in the Czech Republic were asked to participate in the sociological representative survey conducted from November to December 2016, through face-to-face structured interviews comprising 19 items. Factor analysis as well as reliability analysis of items focused on legal rules in the context of physicians' awareness were applied with p-value of < 0.05 as statistically significant.

RESULTS

Of a total of 1237 (79.8%) physicians (43.7% males; mean age 47.5 ± 11.6 years, 46.3% general practitioners) 24.8% considered generic drugs to be less safe, especially those with specialized qualification (p < 0.01). However, only 4.4% of the physicians noticed any drug-related problems, including adverse drug reactions associated with generic substitution. The majority of physicians felt neutrally about performing generic substitution in pharmacies, nor they expressed any opinion on characteristics of generics, even though a better understanding of the legislation and higher need of accordance of substituted drugs were associated with more positive attitudes towards generic substitution (p < 0.05). Physicians showed low knowledge score of legislative rules (mean 3.9 ± 1.6 from maximum 9), nevertheless they overestimated the law, as they considered some rules valid, even if the law does not require them. Cronbach alpha of all legislative rules that regulate generic substitution increased from 0.318 to 0.553 if two optional rules (physician consent and strength equivalence) would be taken into account.

CONCLUSIONS

There is no sufficient awareness of generic drugs and generic substitution related issues among Czech physicians, although a deeper knowledge of legislation improves their perception about providing generic substitution.

摘要

背景

仿制药和仿制药替代属于降低医疗保健成本的工具。然而,医护人员对仿制药的认识不足和不愿意可能会对仿制药替代的合理使用产生负面影响。

方法

本研究旨在分析捷克医生对仿制药和仿制药替代的意见和态度,包括他们对仿制药替代立法规则的理解以及他们在这一领域的以往经验。研究采用随机分配的方式,邀请了 1551 名在捷克共和国执业的医生参加了 2016 年 11 月至 12 月期间进行的一项社会学代表性调查,通过面对面的结构化访谈,共包含 19 个项目。应用因子分析和项目可靠性分析来关注医生意识方面的法律规则,p 值<0.05 为统计学显著。

结果

在总共 1237 名医生中(79.8%)(43.7%为男性;平均年龄 47.5±11.6 岁,46.3%为全科医生),24.8%的医生认为仿制药安全性较低,特别是那些具有专业资格的医生(p<0.01)。然而,只有 4.4%的医生注意到任何与药物相关的问题,包括与仿制药替代相关的不良反应。大多数医生对在药店进行仿制药替代持中立态度,也没有对仿制药的特征发表任何意见,尽管对立法的更好理解和对替代药物的更高需求与对仿制药替代的更积极态度相关(p<0.05)。医生对立法规则的知识得分较低(最高分为 9 分,平均得分为 3.9±1.6),但他们高估了法律,因为他们认为一些规则是有效的,即使法律没有要求他们这样做。如果考虑到两项可选规则(医生同意和强度等效性),则调节仿制药替代的所有立法规则的克朗巴赫阿尔法从 0.318 增加到 0.553。

结论

捷克医生对仿制药和仿制药替代相关问题的认识不足,尽管对立法的深入了解改善了他们对提供仿制药替代的看法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f22/6822393/64d914057a52/12913_2019_4631_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f22/6822393/15f74be44ad4/12913_2019_4631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f22/6822393/64d914057a52/12913_2019_4631_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f22/6822393/15f74be44ad4/12913_2019_4631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f22/6822393/64d914057a52/12913_2019_4631_Fig2_HTML.jpg

相似文献

1
Representative sample survey on factors determining the Czech physicians' awareness of generic drugs and substitution.捷克医生对仿制药和替代药物认知的决定因素的代表性抽样调查
BMC Health Serv Res. 2019 Oct 30;19(1):777. doi: 10.1186/s12913-019-4631-y.
2
Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic.捷克共和国药剂师对仿制药及仿制药替代的看法、态度和经验分析。
Acta Pol Pharm. 2013 Sep-Oct;70(5):923-31.
3
Greek students' attitudes, perception and knowledge regarding generic medicines in times of economic crisis: a cross-sectional study.希腊学生在经济危机时期对仿制药的态度、看法和认知:一项横断面研究。
BMC Med Educ. 2018 Nov 15;18(1):262. doi: 10.1186/s12909-018-1379-8.
4
Knowledge and attitudes of physicians and pharmacists towards the use of generic medicines in Bosnia and Herzegovina.波斯尼亚和黑塞哥维那医生和药剂师对使用非专利药品的认知与态度。
Med Glas (Zenica). 2017 Feb 1;14(1):25-32. doi: 10.17392/867-16.
5
Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.探索社区药剂师对非专利药品替代态度的潜在因素:一项来自波兰的全国性研究。
Int J Clin Pharm. 2016 Feb;38(1):162-70. doi: 10.1007/s11096-015-0227-8. Epub 2015 Nov 30.
6
The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians.尼日利亚通用药物的处方开具:医生的知识、认知与态度
Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):639-650. doi: 10.1586/14737167.2016.1120673. Epub 2015 Dec 28.
7
Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.探索患者对非专利药品替代的看法和体验:一项波兰社会的代表性研究。
Int J Clin Pharm. 2015 Feb;37(1):68-75. doi: 10.1007/s11096-014-0041-8. Epub 2014 Nov 27.
8
A physician survey on generic drugs and substitution of critical dose medications.一项关于仿制药及关键剂量药物替代的医生调查。
Arch Intern Med. 1997 Oct 13;157(18):2080-8.
9
Physicians' Knowledge, Attitude and Practice of Generic Substitution in China: A Cross-Sectional Online Survey.中国医生对仿制药替代的知识、态度和实践:一项横断面在线调查。
Int J Environ Res Public Health. 2021 Jul 21;18(15):7749. doi: 10.3390/ijerph18157749.
10
The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.在一般实践环境中,通用名药物转换对丹麦成年人用药担忧及停药情况的影响。
Dan Med J. 2015 Oct;62(10):B5148.

引用本文的文献

1
Prescription writing pattern among the dental practitioners of a tertiary care hospital in Karachi.卡拉奇一家三级护理医院的牙科医生的处方书写模式。
BMC Prim Care. 2024 Jul 27;25(1):273. doi: 10.1186/s12875-024-02532-z.
2
Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna.维也纳卫生保健专业人员对仿制药或生物类似药的药理学等效性的认知。
Eur J Clin Pharmacol. 2024 Mar;80(3):355-366. doi: 10.1007/s00228-023-03603-3. Epub 2023 Dec 22.

本文引用的文献

1
Factors influencing the use of the "not for generic substitution" mention for prescriptions in primary care: a survey with general practitioners.影响基层医疗中处方“禁止通用名替换”标注使用的因素:一项针对全科医生的调查
BMC Health Serv Res. 2018 Nov 12;18(1):850. doi: 10.1186/s12913-018-3652-2.
2
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.中东欧国家的药品监管:当前综述
Front Pharmacol. 2017 Dec 18;8:892. doi: 10.3389/fphar.2017.00892. eCollection 2017.
3
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
欧美仿制药市场比较:价格、销量与支出
Milbank Q. 2017 Sep;95(3):554-601. doi: 10.1111/1468-0009.12279.
4
Perception and attitude of Korean physicians towards generic drugs.韩国医生对仿制药的认知和态度。
BMC Health Serv Res. 2017 Aug 29;17(1):610. doi: 10.1186/s12913-017-2555-y.
5
Influencers of generic drug utilization: A systematic review.影响仿制药使用的因素:系统评价。
Res Social Adm Pharm. 2018 Jul;14(7):619-627. doi: 10.1016/j.sapharm.2017.08.001. Epub 2017 Aug 4.
6
Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.危地马拉通用药品的认知与使用:一项针对医生和药房工作人员的混合方法研究。
BMC Health Serv Res. 2017 Jan 13;17(1):27. doi: 10.1186/s12913-017-1991-z.
7
Knowledge and attitudes of physicians and pharmacists towards the use of generic medicines in Bosnia and Herzegovina.波斯尼亚和黑塞哥维那医生和药剂师对使用非专利药品的认知与态度。
Med Glas (Zenica). 2017 Feb 1;14(1):25-32. doi: 10.17392/867-16.
8
Generic Medicine Pricing Policies in Europe: Current Status and Impact.欧洲仿制药定价政策:现状与影响
Pharmaceuticals (Basel). 2010 Mar 5;3(3):471-481. doi: 10.3390/ph3030471.
9
Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies.商业数据库与行政数据库利用率的差异:对未来卫生经济及跨国研究的启示
Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):149-52. doi: 10.1586/14737167.2016.1158649. Epub 2016 Mar 17.
10
Generic versus brand-name drugs used in cardiovascular diseases.用于心血管疾病的通用药物与品牌药物。
Eur J Epidemiol. 2016 Apr;31(4):351-68. doi: 10.1007/s10654-015-0104-8. Epub 2015 Nov 30.